News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Pre-TURBT mitomycin-C improves RFS in NMIBC
26 Mar 2026
byAudrey Abella
In the updated 5-year analysis of a randomized phase II trial, administering two doses of intravesical mitomycin-C (MMC) immediately before transurethral resection of bladder tumour (TURBT) improves recurrence-free survival (RFS) in individuals with non-muscle invasive bladder cancer (NMIBC).
Pre-TURBT mitomycin-C improves RFS in NMIBC
26 Mar 2026
Albuminuria an important fracture risk predictor in T2D
26 Mar 2026
byChristina Lau
Albuminuria is an important and independent predictor of hip fractures and major osteoporotic fractures (MOF) in patients with type 2 diabetes (T2D), and the presence of additional metabolic syndrome (MetS)–related traits compounds this fracture risk, particularly in nonobese patients, a population-based retrospective cohort study in Hong Kong has shown.







